Manabu Emi

4.2k total citations · 1 hit paper
98 papers, 3.3k citations indexed

About

Manabu Emi is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Manabu Emi has authored 98 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 62 papers in Surgery, 52 papers in Pulmonary and Respiratory Medicine and 25 papers in Oncology. Recurrent topics in Manabu Emi's work include Esophageal Cancer Research and Treatment (50 papers), Gastric Cancer Management and Outcomes (39 papers) and Esophageal and GI Pathology (35 papers). Manabu Emi is often cited by papers focused on Esophageal Cancer Research and Treatment (50 papers), Gastric Cancer Management and Outcomes (39 papers) and Esophageal and GI Pathology (35 papers). Manabu Emi collaborates with scholars based in Japan and United States. Manabu Emi's co-authors include Kazuaki Tanabe, Ryungsa Kim, Tetsuya Toge, Koji Arihiro, Yoko Uchida, Yoichi Hamai, Jun Hihara, Hideki Inoue, Yuta Ibuki and Tomoaki Kurokawa and has published in prestigious journals such as PLoS ONE, Cancer and Cancer Research.

In The Last Decade

Manabu Emi

95 papers receiving 3.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Cancer immunoediting from immune surveillance to immune escape

2007 796 citations Ryungsa Kim, Manabu Emi et al. profile →

Peers

Countries citing papers authored by Manabu Emi

Since Specialization

Citations

This map shows the geographic impact of Manabu Emi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Manabu Emi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Manabu Emi more than expected).

Fields of papers citing papers by Manabu Emi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Manabu Emi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Manabu Emi. The network helps show where Manabu Emi may publish in the future.

Co-authorship network of co-authors of Manabu Emi

This figure shows the co-authorship network connecting the top 25 collaborators of Manabu Emi. A scholar is included among the top collaborators of Manabu Emi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Manabu Emi. Manabu Emi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Risk factors for recurrence of esophageal squamous cell carcinoma after pathological complete response to neoadjuvant therapy followed by esophagectomy 2024 ·World Journal of Surgery ·(unknown), Yoichi Hamai, Manabu Emi, Yuta Ibuki, Tomoaki Kurokawa, (unknown), (unknown), Morihito Okada	0
2	Recurrence and prognostic predictors in pathologic T1N0 esophageal squamous cell carcinoma treated with surgery alone 2024 ·Surgery ·(unknown), Yoichi Hamai, Manabu Emi, Yuta Ibuki, Tomoaki Kurokawa, (unknown), (unknown), Morihito Okada	1
3	Postoperative Lymph Node Recurrence in Esophageal Cancer After Surgery and Prognosis of Chemoradiotherapy 2024 ·Cancer Diagnosis & Prognosis ·Manabu Emi, Yoichi Hamai, Toru Yoshikawa, (unknown), (unknown), Tomoaki Kurokawa, Yuji Murakami, Ikuno Nishibuchi, Morihito Okada	0
4	Long-term results of chemoradiotherapy with elective nodal irradiation for resectable locally advanced esophageal cancer in three-dimensional planning system 2023 ·International Journal of Clinical Oncology ·(unknown), Ikuno Nishibuchi, Yuji Murakami, (unknown), Nobuki Imano, (unknown), Yoichi Hamai, Manabu Emi, Morihito Okada, Yasushi Nagata	1
5	Esophageal Neuroendocrine Carcinoma With Pathological Complete Response After Neoadjuvant Chemotherapy Followed by Robot-assisted Surgery: A Case Report 2023 ·Anticancer Research ·(unknown), (unknown), Yoichi Hamai, Shohei Yamaguchi, Manabu Emi, Toru Yoshikawa, (unknown), Morihito Okada	0
6	Prognostic factors for esophageal squamous cell carcinoma without pathological lymph node metastasis after neoadjuvant therapy and surgery 2023 ·World Journal of Surgery ·Yoichi Hamai, Manabu Emi, Yuta Ibuki, Yuji Murakami, Ikuno Nishibuchi, Tomoaki Kurokawa, Toru Yoshikawa, (unknown), (unknown), (unknown), Morihito Okada	1
7	Ability of Blood Cell Parameters to Predict Clinical Outcomes of Nivolumab Monotherapy in Advanced Esophageal Squamous Cell Carcinoma 2023 ·OncoTargets and Therapy ·Yoichi Hamai, Manabu Emi, Yuta Ibuki, Tomoaki Kurokawa, Toru Yoshikawa, (unknown), (unknown), (unknown), Morihito Okada	10
8	Recurrent esophageal adenocarcinoma derived from ectopic gastric mucosa: A case report 2022 ·Thoracic Cancer ·(unknown), Yoichi Hamai, Toru Yoshikawa, Manabu Emi, Tomoaki Kurokawa, (unknown), (unknown), Morihito Okada	7
9	Predictions of Pathological Features and Recurrence Based on FDG-PET Findings of Esophageal Squamous Cell Carcinoma after Trimodal Therapy 2020 ·Annals of Surgical Oncology ·Yoichi Hamai, Manabu Emi, Yuta Ibuki, Yuji Murakami, Ikuno Nishibuchi, Yasushi Nagata, (unknown), Tomoaki Kurokawa, (unknown), Toru Yoshikawa, Morihito Okada	8
10	Adult Intussusception Due to Endometriosis Arising from the Uterine Tube: Report of a Case 2018 ·Hiroshima University Acedemic Information Repository (Hiroshima University) ·Toru Yoshikawa, Yuta Ibuki, Mayumi Kaneko, (unknown), Masanori Yoshimitsu, Manabu Emi, Toshihiko Kohashi, Jun Hihara, Hidenori Mukaida, Naoki Hirabayashi	1
11	Complete pathological response of multiple huge liver metastases of colon cancer: a case report 2017 ·Oxford Medical Case Reports ·(unknown), Masanori Yoshimitsu, Manabu Emi, (unknown), Toshihiko Kohashi, Mayumi Kaneko, Hideki Ohdan, Naoki Hirabayashi	1
12	Effects of Neoadjuvant Chemoradiotherapy on Pathological TNM Stage and Their Prognostic Significance for Surgicallytreated Esophageal Squamous Cell Carcinoma 2017 ·Anticancer Research ·Yoichi Hamai, Jun Hihara, Manabu Emi, (unknown), Yuta Ibuki, (unknown), Tomoaki Kurokawa, Morihito Okada	14
13	Involvement of homologous recombination in the synergism between cisplatin and poly (ADP‐ribose) polymerase inhibition 2013 ·Cancer Science ·(unknown), Yoshiro Aoki, Keizo Misumi, Yoichi Hamai, Manabu Emi, Jun Hihara, Lin Shi, (unknown), Yasunori Horikoshi, Jiying Sun, Tsuyoshi Ikura, Morihito Okada, Satoshi Tashiro	23
14	Esophageal Bypass Operation Prior to Definitive Chemoradiotherapy in Advanced Esophageal Cancer With Tracheobronchial Invasion 2013 ·The Annals of Thoracic Surgery ·Jun Hihara, Yoichi Hamai, Manabu Emi, Yoshiro Aoki, Junya Taomoto, Yoshihiro Miyata, Morihito Okada	23
15	Successful management of multiple esophagorespiratory fistulas using two types of stent: Report of a case 2011 ·Surgery Today ·Yoichi Hamai, Jun Hihara, Manabu Emi, (unknown), Katsuhiko Shimizu, Morihito Okada	10
16	Phase I study of docetaxel (TXT) and 5-fluorouracil (5-FU) with concurrent radiotherapy in patients with advanced esophageal cancer. 2007 ·PubMed ·Jun Hihara, Kazuhiro Yoshida, Yoichi Hamai, Manabu Emi, Yoshiyuki Yamaguchi, Koichi Wadasaki	23
17	A CASE OF GIST OF DUODENUM SUCCESSFULLY TREATED WITH NEOADJUVANT IMATINIB AND LIMITED SURGERY 2007 ·Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association) ·Manabu Emi, Kazuhiro Yoshida, Jun Hihara, Yoichi Hamai, Yoshiyuki Yamaguchi, Morihito Okada	2
18	A CASE OF ASYMPTOMATIC TRAUMATIC RIGHT DIAPHRAGMATIC HERNIA WITH DISLOCATION OF THE WHOLE LIVER AND RIGHT HEMICOLON 2007 ·Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association) ·Manabu Emi, Kazuhiro Yoshida, Katsuhiko Shimizu, Jun Hihara, (unknown), Yoshiyuki Yamaguchi	2
19	Potential role of HER-2; in primary breast tumor with bone metastasis 2006 ·Oncology Reports ·Ryungsa Kim, Koji Arihiro, Manabu Emi, Kazuaki Tanabe, Akihiko Osaki	11
20	Current status of the molecular mechanisms of anticancer drug-induced apoptosis 2002 ·Cancer Chemotherapy and Pharmacology ·Ryungsa Kim, Kazuaki Tanabe, Yoko Uchida, Manabu Emi, Hideki Inoue, Tetsuya Toge	221

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact